News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mallinckrodt Inc. Pays $3.5 Million to Settle Kickback Charges


7/23/2013 7:30:09 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Three days after the US Department of Justice formally joined a whistleblower lawsuit against Mallinckrodt, the drugmaker has agreed to pay $ 3.5 million to settle charges that kickbacks were paid to physicians to prescribe certain drugs and that the ensuing activity caused Medicare and Medicaid to be overcharged. The details tell a familiar tale. Specifically, Mallinckrodt paid physician to participate in speaker programs, clinical trials and meetings, or in some cases, complete forms that provided them incentives to write prescriptions for the Restoril sleeping pill, the Magnacet painkiller and the Tofranil antidepressants, or their generic equivalents.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES